These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 17389503

  • 1. Changes in Toll-like receptor (TLR)-2 and TLR4 expression and function but not polymorphisms are associated with acute anterior uveitis.
    Chang JH, Hampartzoumian T, Everett B, Lloyd A, McCluskey PJ, Wakefield D.
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1711-7. PubMed ID: 17389503
    [Abstract] [Full Text] [Related]

  • 2. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, Akashi S, Miyake K, Godowski PJ, Makino H.
    Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
    [Abstract] [Full Text] [Related]

  • 3. Alterations in inflammatory capacity and TLR expression on monocytes and neutrophils after cardiopulmonary bypass.
    Hadley JS, Wang JE, Michaels LC, Dempsey CM, Foster SJ, Thiemermann C, Hinds CJ.
    Shock; 2007 May; 27(5):466-73. PubMed ID: 17438450
    [Abstract] [Full Text] [Related]

  • 4. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
    Skinner NA, MacIsaac CM, Hamilton JA, Visvanathan K.
    Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
    [Abstract] [Full Text] [Related]

  • 5. Toll-like receptor 2 and 4 expression after severe injury is not involved in the dysregulation of the innate immune system.
    Lendemans S, Kreuzfelder E, Rani M, Bayeeh E, Schade FU, Flohé SB, Waydhas C, Flohé S.
    J Trauma; 2007 Oct; 63(4):740-6. PubMed ID: 18089999
    [Abstract] [Full Text] [Related]

  • 6. Selective impairment of Toll-like receptor 2-mediated proinflammatory cytokine production by monocytes from patients with atopic dermatitis.
    Hasannejad H, Takahashi R, Kimishima M, Hayakawa K, Shiohara T.
    J Allergy Clin Immunol; 2007 Jul; 120(1):69-75. PubMed ID: 17531301
    [Abstract] [Full Text] [Related]

  • 7. Leukocyte toll-like receptor expression in end-stage kidney disease.
    Gollapudi P, Yoon JW, Gollapudi S, Pahl MV, Vaziri ND.
    Am J Nephrol; 2010 Jul; 31(3):247-54. PubMed ID: 20090311
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of exercise training and age on CD14+ cell-surface expression of toll-like receptor 2 and 4.
    Stewart LK, Flynn MG, Campbell WW, Craig BA, Robinson JP, McFarlin BK, Timmerman KL, Coen PM, Felker J, Talbert E.
    Brain Behav Immun; 2005 Sep; 19(5):389-97. PubMed ID: 15963685
    [Abstract] [Full Text] [Related]

  • 12. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.
    Sukkar MB, Xie S, Khorasani NM, Kon OM, Stanbridge R, Issa R, Chung KF.
    J Allergy Clin Immunol; 2006 Sep; 118(3):641-8. PubMed ID: 16950283
    [Abstract] [Full Text] [Related]

  • 13. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis.
    Mao TK, Lian ZX, Selmi C, Ichiki Y, Ashwood P, Ansari AA, Coppel RL, Shimoda S, Ishibashi H, Gershwin ME.
    Hepatology; 2005 Oct; 42(4):802-8. PubMed ID: 16175622
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differential toll-like receptor expression after ex vivo lipopolysaccharide exposure in patients with sepsis and following surgical stress.
    Tsujimoto H, Ono S, Majima T, Efron PA, Kinoshita M, Hiraide H, Moldawer LL, Mochizuki H.
    Clin Immunol; 2006 May; 119(2):180-7. PubMed ID: 16517212
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased Toll-like receptor-2 expression on nonclassic CD16+ monocytes from patients with inflammatory stage of Eales' disease.
    Sen A, Chowdhury IH, Mukhopadhyay D, Paine SK, Mukherjee A, Mondal LK, Chatterjee M, Bhattacharya B.
    Invest Ophthalmol Vis Sci; 2011 Sep 01; 52(9):6940-8. PubMed ID: 21791592
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human monocytoid cells as a model to study Toll-like receptor-mediated activation.
    Remer KA, Brcic M, Sauter KS, Jungi TW.
    J Immunol Methods; 2006 Jun 30; 313(1-2):1-10. PubMed ID: 16720029
    [Abstract] [Full Text] [Related]

  • 20. A study of innate immunity in patients with end-stage renal disease: special reference to toll-like receptor-2 and -4 expression in peripheral blood monocytes of hemodialysis patients.
    Kuroki Y, Tsuchida K, Go I, Aoyama M, Naganuma T, Takemoto Y, Nakatani T.
    Int J Mol Med; 2007 May 30; 19(5):783-90. PubMed ID: 17390084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.